Skip to main content
TipRanks
Go Ultimate75% OFF

Graeme Neville Duncan Insider Profile

4 Followers

Graeme Neville Duncan, former Senior Officer at ADVANZ PHARMA, holds 10.27K shares in ADVANZ PHARMA (Ticker: CXRXF). Most recently, Graeme Neville Duncan Bought 10,265 shares of ADVANZ PHARMA on Sep 13, 2018 for an estimated value of $140.53K.

Graeme Neville Duncan's Trading History

CXRXF
ADVANZ PHARMA
Sep 13, 2018―Informative Buy140.53K$175.89K
CXRXF
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Sep 13, 2018Informative Buy$140.53K10,265$13.69-18.20%―
May 18, 2017Informative SellC$13.69K7,165C$1.91+77.00%―

You May Also Like

Graeme Neville Duncan insider profile FAQ

What is the percentage of profitable transactions made by Graeme Neville Duncan?
The percentage of profitable transactions made by Graeme Neville Duncan is 50%.
What is the average return per transaction made by Graeme Neville Duncan?
The average return per transaction made by Graeme Neville Duncan is 29.40%.
What stocks does Graeme Neville Duncan hold?
Graeme Neville Duncan holds: CXRXF stocks.
What was Graeme Neville Duncan’s latest transaction?
Graeme Neville Duncan’s latest transaction was an Informative Buy of $140.53K.
What was Graeme Neville Duncan's most profitable transaction?
Graeme Neville Duncan’s most profitable transaction was an Informative Sell of CXRXF stock on May 18, 2017. The return on the trade was 77.00%.
What is Graeme Neville Duncan's role in ADVANZ PHARMA?
Graeme Neville Duncan's role in ADVANZ PHARMA is Senior Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.